HDAC9 and neoplasm: Multiple experimental studies have utilized melanoma mouse models, generated by B16 cell line, in order to evaluate the efficacy of HDAC inhibition, combined with vaccines or other immunotherapeutic approaches in containing tumor outgrowth.